Identification and characterization of permissive cells to dengue virus infection in human hematopoietic stem and progenitor cells

Alan Y. Hsu, Tzu Chuan Ho, Mei Ling Lai, Sia Seng Tan, Tsai-Yun Chen, Meed Lee, Yu-Wen Chien, Ya-Ping Chen, Guey-Chuen Perng

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Dengue virus (DENV) is a significant threat to public health in tropical and subtropical regions, where the frequency of human migration is increasing. Transmission of DENV from donors to recipients after hematopoietic stem cell transplantation has been steadily described. However, the underlying mechanisms remain unclear. STUDY DESIGN AND METHODS: Freshly isolated bone marrow (BM) was subjected to DENV infection, followed by multicolor fluorescence-activated cell sorting (FACS) analysis. Virus in supernatants was collected and analyzed by plaque assay. RESULTS: DENV-1 to DENV-4 could effectively infect freshly obtained BM and produced infectious virus. DENV infection did not change the quantitative population of hematopoietic stem and progenitor cells (HSPCs), megakaryocytic progenitor cells (MkPs) and megakaryocytes. Additionally, DENV antigen, nonstructural protein 1, was enriched in HSPCs and MkPs of DENV infected marrow cells. CD34+, CD133+, or CD61+ cells sorted out from BM were not only the major contributing targets facilitating the DENV infection directly but also facilitated the spread of DENV into other cells when cocultured. CONCLUSION: Results suggest that DENV can efficiently infect HSPCs, which might jeopardize the recipients if DENV-infected cells were subsequently used. We therefore raise the need for DENV screening for both the donors and recipients of hematopoietic stem cell transplantation, especially for donors exposed to endemic areas, to mitigate DENV infection in immunocompromised recipients.

Original languageEnglish
Pages (from-to)2938-2951
Number of pages14
JournalTransfusion
Volume59
Issue number9
DOIs
Publication statusPublished - 2019 Sep 1

Fingerprint

Dengue Virus
Virus Diseases
Hematopoietic Stem Cells
Bone Marrow
Hematopoietic Stem Cell Transplantation
Human Migration
Megakaryocyte Progenitor Cells
Viruses
Donor Selection

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Hematology

Cite this

@article{ee6d7c171464464590207a228288861f,
title = "Identification and characterization of permissive cells to dengue virus infection in human hematopoietic stem and progenitor cells",
abstract = "BACKGROUND: Dengue virus (DENV) is a significant threat to public health in tropical and subtropical regions, where the frequency of human migration is increasing. Transmission of DENV from donors to recipients after hematopoietic stem cell transplantation has been steadily described. However, the underlying mechanisms remain unclear. STUDY DESIGN AND METHODS: Freshly isolated bone marrow (BM) was subjected to DENV infection, followed by multicolor fluorescence-activated cell sorting (FACS) analysis. Virus in supernatants was collected and analyzed by plaque assay. RESULTS: DENV-1 to DENV-4 could effectively infect freshly obtained BM and produced infectious virus. DENV infection did not change the quantitative population of hematopoietic stem and progenitor cells (HSPCs), megakaryocytic progenitor cells (MkPs) and megakaryocytes. Additionally, DENV antigen, nonstructural protein 1, was enriched in HSPCs and MkPs of DENV infected marrow cells. CD34+, CD133+, or CD61+ cells sorted out from BM were not only the major contributing targets facilitating the DENV infection directly but also facilitated the spread of DENV into other cells when cocultured. CONCLUSION: Results suggest that DENV can efficiently infect HSPCs, which might jeopardize the recipients if DENV-infected cells were subsequently used. We therefore raise the need for DENV screening for both the donors and recipients of hematopoietic stem cell transplantation, especially for donors exposed to endemic areas, to mitigate DENV infection in immunocompromised recipients.",
author = "Hsu, {Alan Y.} and Ho, {Tzu Chuan} and Lai, {Mei Ling} and Tan, {Sia Seng} and Tsai-Yun Chen and Meed Lee and Yu-Wen Chien and Ya-Ping Chen and Guey-Chuen Perng",
year = "2019",
month = "9",
day = "1",
doi = "10.1111/trf.15416",
language = "English",
volume = "59",
pages = "2938--2951",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "9",

}

Identification and characterization of permissive cells to dengue virus infection in human hematopoietic stem and progenitor cells. / Hsu, Alan Y.; Ho, Tzu Chuan; Lai, Mei Ling; Tan, Sia Seng; Chen, Tsai-Yun; Lee, Meed; Chien, Yu-Wen; Chen, Ya-Ping; Perng, Guey-Chuen.

In: Transfusion, Vol. 59, No. 9, 01.09.2019, p. 2938-2951.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Identification and characterization of permissive cells to dengue virus infection in human hematopoietic stem and progenitor cells

AU - Hsu, Alan Y.

AU - Ho, Tzu Chuan

AU - Lai, Mei Ling

AU - Tan, Sia Seng

AU - Chen, Tsai-Yun

AU - Lee, Meed

AU - Chien, Yu-Wen

AU - Chen, Ya-Ping

AU - Perng, Guey-Chuen

PY - 2019/9/1

Y1 - 2019/9/1

N2 - BACKGROUND: Dengue virus (DENV) is a significant threat to public health in tropical and subtropical regions, where the frequency of human migration is increasing. Transmission of DENV from donors to recipients after hematopoietic stem cell transplantation has been steadily described. However, the underlying mechanisms remain unclear. STUDY DESIGN AND METHODS: Freshly isolated bone marrow (BM) was subjected to DENV infection, followed by multicolor fluorescence-activated cell sorting (FACS) analysis. Virus in supernatants was collected and analyzed by plaque assay. RESULTS: DENV-1 to DENV-4 could effectively infect freshly obtained BM and produced infectious virus. DENV infection did not change the quantitative population of hematopoietic stem and progenitor cells (HSPCs), megakaryocytic progenitor cells (MkPs) and megakaryocytes. Additionally, DENV antigen, nonstructural protein 1, was enriched in HSPCs and MkPs of DENV infected marrow cells. CD34+, CD133+, or CD61+ cells sorted out from BM were not only the major contributing targets facilitating the DENV infection directly but also facilitated the spread of DENV into other cells when cocultured. CONCLUSION: Results suggest that DENV can efficiently infect HSPCs, which might jeopardize the recipients if DENV-infected cells were subsequently used. We therefore raise the need for DENV screening for both the donors and recipients of hematopoietic stem cell transplantation, especially for donors exposed to endemic areas, to mitigate DENV infection in immunocompromised recipients.

AB - BACKGROUND: Dengue virus (DENV) is a significant threat to public health in tropical and subtropical regions, where the frequency of human migration is increasing. Transmission of DENV from donors to recipients after hematopoietic stem cell transplantation has been steadily described. However, the underlying mechanisms remain unclear. STUDY DESIGN AND METHODS: Freshly isolated bone marrow (BM) was subjected to DENV infection, followed by multicolor fluorescence-activated cell sorting (FACS) analysis. Virus in supernatants was collected and analyzed by plaque assay. RESULTS: DENV-1 to DENV-4 could effectively infect freshly obtained BM and produced infectious virus. DENV infection did not change the quantitative population of hematopoietic stem and progenitor cells (HSPCs), megakaryocytic progenitor cells (MkPs) and megakaryocytes. Additionally, DENV antigen, nonstructural protein 1, was enriched in HSPCs and MkPs of DENV infected marrow cells. CD34+, CD133+, or CD61+ cells sorted out from BM were not only the major contributing targets facilitating the DENV infection directly but also facilitated the spread of DENV into other cells when cocultured. CONCLUSION: Results suggest that DENV can efficiently infect HSPCs, which might jeopardize the recipients if DENV-infected cells were subsequently used. We therefore raise the need for DENV screening for both the donors and recipients of hematopoietic stem cell transplantation, especially for donors exposed to endemic areas, to mitigate DENV infection in immunocompromised recipients.

UR - http://www.scopus.com/inward/record.url?scp=85068210258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068210258&partnerID=8YFLogxK

U2 - 10.1111/trf.15416

DO - 10.1111/trf.15416

M3 - Article

VL - 59

SP - 2938

EP - 2951

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 9

ER -